Morgan Stanley analyst Betsy Graseck maintains Bank of America (NYSE:BAC) with a Equal-Weight and lowers the price target from $37 to $31.
Morgan Stanley lowered Bank of America (NYSE:BAC) price target to $31 Read Post »
Goldman Sachs analyst Mike Burton maintains Arista Networks (NYSE:ANET) with a Buy and raises the price target from $170 to $190.
Goldman Sachs raised Arista Networks (NYSE:ANET) price target to $190 Read Post »
Needham Adjusts CrowdStrike (NASDAQ:CRWD) Price Target to $170 From $165, Maintains Buy Rating。
Needham Adjusts CrowdStrike (NASDAQ:CRWD) Price Target to $170 Read Post »
Barclays analyst Saket Kalia maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Overweight and lowers the price target from $165 to $162.
Barclays lowered CrowdStrike Holdings (NASDAQ:CRWD) price target to $162 Read Post »
Bank of America Securities analyst Craig Siegenthaler maintains Blackstone (NYSE:BX) with a Buy and lowers the price target from $115 to $98.
Bank of America lowered Blackstone (NYSE:BX) price target to $98 Read Post »
Wells Fargo analyst Elyse Greenspan maintains American Intl Gr (NYSE:AIG) with a Equal-Weight and lowers the price target from $61 to $58.
Wells Fargo lowered American Intl Gr (NYSE:AIG) price target to $58 Read Post »
Jefferies analyst Brent Thill maintains Meta Platforms (NASDAQ:META) with a Buy and raises the price target from $225 to $250.
Jefferies raises Meta Platforms (NASDAQ:META) price target to $250 Read Post »
Barclays Adjusts Marathon Petroleum (NYSE:MPC) Price Target to $139 From $130, Maintains Overweight Rating.
Barclays Adjusts Marathon Petroleum (NYSE:MPC) Price Target to $139 Read Post »
Wells Fargo Adjusts Price Target on MetLife (NYSE:MET) to $72 From $84, Maintains Overweight Rating.
Wells Fargo Adjusts Price Target on MetLife (NYSE:MET) to $72 Read Post »
Goldman Sachs analyst Alex Scott maintains MetLife (NYSE:MET) with a Neutral and lowers the price target from $79 to $65.
Goldman Sachs lowered MetLife (NYSE:MET) price target to $65 Read Post »
Bank of America Securities analyst Matthew DeYoe downgrades Albemarle (NYSE:ALB) from Neutral to Underperform and lowers the price target from $262 to $195.
Bank of America lowered Albemarle (NYSE:ALB) price target to $195 Read Post »
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $140 to $136.
Wells Fargo lowered Abbott Laboratories (NYSE:ABT) price target to $136 Read Post »